Dirk Gevers
Global Head, Janssen Human Microbiome Institute
When
23rd May 2018
Where
New York, USA
New York Academy of Medicine
Microbiome Futures is a landmark forum that will document the future of microbiome research and commercialisation.
The live event, on May 23, will be the culmination of a thorough research process, during which the working group will be gathering input from a global pool of stakeholders in the microbiome space. It will feature a roundtable discussion, moderated by Susan Jones, Senior Editor at Nature Biotechnology and Gaspar Taroncher-Oldenburg, consultant-in-residence for Global Engage.
Combining the summary and analysis of the roundtable discussion, the working group’s feedback, and the KOLs’ input, it will be published as the Roadmap for Microbiome Translation white paper in Nature Biotechnology.
The unique opportunity to participate in charting the future of the microbiome space.
Join a select group of leading scientists, business executives, investors and stakeholders to collaboratively discuss the future of microbiome translation.
A panel of leaders in the field will lead discussions with the audience in a unique, collegial forum to create and publish a road map for microbiome translation.
Conversations with KOLs have begun, and the advisory panel is being formed, ready for the progam launch in November.
Want to be the first to hear about it? Sign up below.
To be the first to get the final panel member list, agenda and a special launch offer, sign up here.
New York Academy of Medicine
1216 5th Avenue, New York, NY 10029, USA
Located in a historic Fifth Avenue building on Museum Mile, the New York Academy of Medicine is the ideal venue to come together with your peers to decide on the future of microbiome.
To register, please phone +44 1865 849841 or complete the form below to pay online.
$325.00
Great expectations have been raised over the last two decades by advances made in unlocking the mysteries of the microbiome and by first inroads taken into harnessing the resulting scientific insights for wellness and therapeutic purposes.
Microbial ecology and synthetic biology are rapidly becoming allies in the race to develop novel therapeutic strategies in the microbiome space.
“We need a shift from correlation to causation to support further progress,” says Weizmann Institute of Science’s Eran Elinav, echoing a widely espoused sentiment in the microbiome space.
Subscribe to our microbiome futures newsletter to be the first to get the final panel list and agenda.
For companies wishing to have exposure through association with the Global Translational Roadmap, both onsite during the discussion group and longer term through publication and distribution of the roadmap white paper, a limited number of sponsorship and partnering opportunities are available.
To receive the full list of package options, email [email protected].
Call us on +44 1865 849841
For details on attendees, packages and new opportunities, please contact our sponsorship team who will quickly provide everything you need to assess the conference for yourself.
